Table 2.
Benefit | ||||||
---|---|---|---|---|---|---|
Renal | ||||||
Study | Model | Treatment | Proteinuria | function | Histology | Remarks |
Schwarz et al. [24] | Subtotally nephrectomy | Calcitriol | Reduce | n/a | Less glomerulosclerosis | No change in BP; benefit not related to PTH |
Hirata et al. [25] | Subtotally nephrectomy | 22-oxacalcitriol | Reduce | n/a | Less glomerulosclerosis | |
Mizobuchi et al. [26] | Subtotally nephrectomy | Paricalcitol | Reduce | Improve | Less glomerulosclerosis | Possibly a higher TI volume |
Migliori et al. [27] | Thy1.1 glomerulonephritis | Calcitriol | Reduce | n/a | Less glomerular damage | |
Tan et al. [28] | Obstructive nephropathy | Paricalcitol | n/a | n/a | Less TI damage |
BP, blood pressure; PTH, parathyroid hormone; TI, tubulointerstitial; n/a, not assessed.